Postby mpbser » Fri Jan 18, 2019 6:43 pm
Yes, there is the same risk with biopsy of the liver. You call it "seeding", here we call is "spreading." That is why I wrote, "One concern originally was risk of spread via the percutaneous biopsy needle if indeed it is cancerous."
"If MSK recommend/do the surgery and the pathology says it is not cancer - I presume that is it and they will not implant the HAI pump?"
I don't know, although I am not sure I understood your question. I can't see MSK recommending surgery without implanting the pump at the same time as the surgery.
Another option that Mass General had suggested was to watch and wait. Given the seriousness of possible metastasis, my husband and I were rather surprised by such a suggestion. But now, going through all this, we get it. That's something we plan on asking on Monday. Once we hear the doctor out, we will definitely ask about alternatives.
Wife 4/17 Dx age 45
5/17 LAR
Adenocarcinoma
low grade
1st primary T3 N2b M1a
Stage IVA
8/17 Sub-total colectomy
2nd primary 5.5 cm T1 N0
9 of 96 nodes
CEA: < 2.9
MSS
Lynch no; KRAS wild
Immunohistochemsistry Normal
Fall 2017 FOLFOX shrank the 1 met in liver
1/18 Liver left hepatectomy seg 4
5/18 CT clear
12/18 MRI 1 liver met
3/7/19 Resection & HAI
4/1/19 Folfiri & FUDR
5/13/19 HAI pump catheter dislodge, nearly bled to death
6-7 '19 5FU 4 cycles
NED